ProQR Therapeutics Eulerpool News

ProQR Therapeutics Eulerpool News

ProQR Therapeutics Notizie Azioni

ProQR Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie ProQR Therapeutics.

• 22 maggio ·

  TipRanks
  ProQR Shareholders Approve Key Resolutions
• 13 maggio ·

  Yahoo
  Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago
• 11 maggio ·

  SeekingAlpha
  ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript)
• 10 maggio ·

  TipRanks
  Buy Rating Affirmed for ProQR on Promising RNA Editing Technology and Solid Financial Footing
• 10 maggio ·

  TipRanks
  ProQR’s Axiomer Platform Technology Shows Promise: Analyst Maintains Buy Rating on Robust Editing Efficacy and Clinical Development Potential
• 9 maggio ·

  Yahoo
  ProQR Announces First Quarter 2024 Operating and Financial Results
• 9 maggio ·

  TipRanks
  ProQR Therapeutics Reports Quarterly Financials
• 9 maggio ·

  Seeking Alpha
  ProQR GAAP EPS of -€0.09, revenue of €4.45M
• 9 maggio ·

  Thefly.com
  ProQR Therapeutics reports Q1 EPS (EUR 0.09) vs. (EUR 0.11) last year
• 8 maggio ·

  Yahoo
  ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases